Phillips Wealth Planners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.12M Sell
5,043
-625
-11% -$146K 0.84% 33
2025
Q4
$1.24M Buy
5,668
+181
+3% +$35.8K 0.99% 24
2025
Q3
$1.03M Buy
5,487
+588
+12% +$101K 0.86% 28
2025
Q2
$763K Buy
4,899
+42
+0.9% +$6.46K 0.69% 40
2025
Q1
$737K Buy
4,857
+1,366
+39% +$214K 0.78% 38
2024
Q4
$496K Sell
3,491
-1,515
-30% -$235K 0.5% 65
2024
Q3
$822K Buy
5,006
+833
+20% +$133K 0.79% 30
2024
Q2
$624K Buy
4,173
+14
+0.3% +$2.08K 0.66% 37
2024
Q1
$601K Buy
4,159
+125
+3% +$19.9K 0.69% 36
2023
Q4
$650K Sell
4,034
-172
-4% -$26.4K 0.78% 35
2023
Q3
$641K Sell
4,206
-34
-0.8% -$5.61K 0.87% 34
2023
Q2
$702K Sell
4,240
-547
-11% -$88.3K 0.92% 33
2023
Q1
$783K Buy
4,787
+145
+3% +$23.4K 1.04% 28
2022
Q4
$755K Buy
+4,642
New +$802K 1.32% 22

Other funds holding JNJ

Phillips Wealth Planners's JNJ Position: Q1 2026 in Review

Phillips Wealth Planners reduced its Johnson & Johnson (JNJ) stake by 11% in Q1 2026, selling an estimated $146K and leaving 5,043 shares worth $1.12M. The position accounts for 0.84% of the portfolio, ranked #33.

Phillips Wealth Planners first reported a position in JNJ in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.24M in Q4 2025. 4,614 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Phillips Wealth Planners held 5,043 shares of Johnson & Johnson worth $1.12M as of Q1 2026.
  • Phillips Wealth Planners sold 625 Johnson & Johnson shares in Q1 2026, an estimated $146K.
  • Johnson & Johnson made up 0.84% of Phillips Wealth Planners's portfolio in Q1 2026, its #33 holding.
  • Phillips Wealth Planners first reported a position in Johnson & Johnson in Q4 2022 and has held it in 14 quarters since.
  • Phillips Wealth Planners's Johnson & Johnson position peaked at $1.24M in Q4 2025.
  • 4,614 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Phillips Wealth Planners's 13F filing for Q1 2026, filed 14 May 2026.